US Patent Number

8198291

Publication Date

6-12-2012

Abstract

The present invention relates to pharmaceutical compositions for intranasal administration to a mammal that contain an effective amount of an opioid, a liquid nasal carrier for the opioid, and optionally a sweetener, flavoring agent or masking agent. In some embodiments of the present invention, the pharmaceutical compositions have improved bioavailability. In other embodiments of the present invention, the opioid compositions improve patient compliance.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

12/755,691

Filing Date

04/07/2010

Share

COinS